SCHEMBL8318209

SCHEMBL8318209

O=C(O)CC(O)CC(O)/C=C/c1c(C2CC2)nc2ccc(Cl)cc2c1-c1ccccc1

nearest known ligand 0.71

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
NR4A2 P43354 2/20 0.71
PDE4D Q08499 2/20 0.71
NR1I2 O75469 1/20 0.71
HMGCR P04035 4/20 0.61
RXRA P19793 3/20 0.61
FABP4 P15090 5/20 0.55
FABP5 Q01469 4/20 0.55
KDM4E B2RXH2 1/20 0.42
FABP3 P05413 4/20 0.40
CYP2C9 P11712 3/20 0.39
SIRT6 Q8N6T7 2/20 0.39
TBXA2R P21731 2/20 0.39
ADRA1A P35348 2/20 0.39
ABCC3 O15438 1/20 0.39
ABCB11 O95342 1/20 0.39
PGR P06401 1/20 0.39
ADORA3 P0DMS8 1/20 0.39
CCKAR P32238 1/20 0.39
PTGS2 P35354 1/20 0.39
SLC10A1 Q14973 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8321515 0.95 PDE4D (0.69) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL8321759 0.92 PDE4D (0.78) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL8318443 0.90 NR4A2 (0.83) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL8323363 0.89 NR4A2 (0.71) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL4422434 0.89 NR4A2 (0.88) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL8319507 0.89 NR4A2 (0.88) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL4422430 0.89 NR4A2 (0.88) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL8323698 0.89 PDE4D (0.65) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL8323630 0.85 NR4A2 (0.68) NR4A2PDE4DNR1I2HMGCRRXRA
SCHEMBL8323292 0.85 PDE4D (0.62) NR4A2PDE4DNR1I2HMGCRRXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0304063-B1 Quinoline type mevalonolactones NISSAN CHEMICAL IND LTD (JP) 1994-11-30 EP claimed
EP-0304063-A2 Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1989-02-22 EP claimed
US-5872130-A ANTI-HYPERLIPIDEMIC, HYPOLIPOPROTEINEMIC AND ANTI-ATHEROSCLEROTIC AGENTS NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1999-02-16 US disclosed
US-5856336-A Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1999-01-05 US disclosed
US-5854259-A Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1998-12-29 US disclosed
EP-0304063-B1 Quinoline type mevalonolactones NISSAN CHEMICAL IND LTD (JP) 1994-11-30 EP disclosed
US-5185328-A Hydroxy-3-methylglutaryl/3-/ coenzyme A reductase inhibitors NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1993-02-09 US disclosed
US-5102888-A QUINOLINE TYPE MEVALONOLACTONES USEFUL FOR TREATING HYPERLIPIDEMIA AND RELATED DISEASES NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1992-04-07 US disclosed
US-5011930-A Antilipemic agents, anticoagulants NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1991-04-30 US disclosed
EP-0304063-A2 Quinoline type mevalonolactones NISSAN CHEMICAL INDUSTRIES LTD. (JP) 1989-02-22 EP disclosed